<DOC>
	<DOCNO>NCT00725127</DOCNO>
	<brief_summary>Brief summary : Aspirin ( ASA ) show provide mark benefit primary secondary prevention cardiovascular event . Substantial evidence suggest low-dose ASA therapy also use primary prevention strategy men woman diabetes high cardiovascular risk . On hand , current evidence potential benefit low-dose ASA therapy subject impair fast glucose , include metabolic syndrome . Most important , previous laboratory animal clinical trial research convincingly demonstrate administration time-dependent ( reference circadian rhythm ) effect ASA . Thus , effect ASA upon lipoperoxides , b-adrenergic receptor , blood pressure ( BP ) clinically healthy subject depend circadian timing ASA administration . The administration-time-dependent influence ASA BP previously demonstrate randomized trial healthy woman independent double-blind , randomize , placebo-controlled clinical trial conduct , first , clinically healthy subject , second one normotensive hypertensive subject , third one pregnant woman high risk preeclampsia fourth one previously untreated patient mild hypertension . The finding BP study consistent ; BP-lowering effect low-dose ASA achieve administered bedtime upon awaken . In keep chronopharmacological effect ASA previous finding suggest ASA low dose may exert potential beneficial effect BP , endothelium function cardiovascular function , prospective , randomize , parallel-arm study investigate potential influence ASA primary prevention cardiovascular , cerebrovascular renal event subject either impaired fasting glucose ( ≥ 100 mg/dl ) previous diagnosis type 2 diabetes mellitus , receive low-dose ASA ( 100 mg/day ) different circadian time ( upon awaken bedtime ) relation rest-activity cycle .</brief_summary>
	<brief_title>Chronotherapy With Low-dose Aspirin Primary Prevention</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Male female subject ≥ 50 year age . Impaired fast glucose ( ≥ 100 &lt; 126 mg/dl ) last available blood test prior ( ≤ 3 month ) randomization , diagnosis type 2 diabetes prior randomization . All subject must randomization conventional clinic systolic/diastolic BP &lt; 160/100 mmHg . Informed consent participate study prior study procedure . Known suspect contraindication , include history allergy ASA . Uncontrolled essential hypertension Grade 23 , i.e. , systolic BP ≥ 160 mmHg and/or diastolic BP ≥ 100 mmHg randomization . Evidence secondary form hypertension , include coarctation aorta , hyperaldosteronism , renal artery stenosis , pheochromocytoma . Known KeithWagener grade III IV hypertensive retinopathy . History hypertensive encephalopathy , cerebrovascular event , transient ischemic cerebral attack , myocardial infarction prior randomization . Type 1 diabetes mellitus . History heart failure . Second third degree heart block without pacemaker . Concomitant unstable angina pectoris . Concomitant potentially life threaten arrhythmia symptomatic arrhythmia . Clinically significant valvular heart disease . Evidence hepatic disease determine one following : ALT AST value &gt; 2 x UNL know randomization , history hepatic encephalopathy , history esophageal varix , history portocaval shunt . Diagnosis chronic kidney disease prior randomization . History malignancy include leukemia lymphoma ( basal cell skin cancer ) , severe , lifethreatening disease within past five year . Any previous history systemic autoimmune disease . History drug alcohol abuse within last two year . Use disallow concomitant medication . Inability communicate comply study requirement . Persons directly involved execution protocol .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>Chronotherapy</keyword>
	<keyword>Primary prevention</keyword>
	<keyword>Impaired fasting glucose</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Total mortality</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Stroke</keyword>
	<keyword>Angina pectoris</keyword>
	<keyword>Chronic kidney disease</keyword>
</DOC>